Haleon plc (HLNCF)

Market Cap	43.90B
Revenue (ttm)	15.10B
Net Income (ttm)	2.09B
Shares Out	n/a
EPS (ttm)	0.23
PE Ratio	21.05
Forward PE	18.87
Dividend	0.09 (1.85%)
Ex-Dividend Date	Aug 14, 2025

Volume	4,456
Average Volume	6,839
Open	4.935
Previous Close	4.925
Day's Range	4.920 - 4.935
52-Week Range	4.000 - 5.800
Beta	0.24
RSI	53.14
Earnings Date	Feb 25, 2026

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1715
• Employees: 24,561
• Stock Exchange: OTCMKTS
• Ticker Symbol: HLNCF

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.

Financial numbers in GBP